Global Human Rho(D) Immune Globulin Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Human Rho(D) Immune Globulin Market Research Report 2024
Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
According to Mr Accuracy reports’s new survey, global Human Rho(D) Immune Globulin market is projected to reach US$ 62 million in 2034, increasing from US$ 35 million in 2022, with the CAGR of 7.1% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Rho(D) Immune Globulin market research.
Key manufacturers engaged in the Human Rho(D) Immune Globulin industry include СЅL Веhrіng, Grіfоlѕ, Bayer, Kedrion Biopharma and Saol Therapeutics, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Human Rho(D) Immune Globulin were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Human Rho(D) Immune Globulin market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Rho(D) Immune Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
СЅL Веhrіng
Grіfоlѕ
Bayer
Kedrion Biopharma
Saol Therapeutics
Segment by Type
Vial
Prefilled Syringe
Government Institution
Private Sector
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Human Rho(D) Immune Globulin report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Human Rho(D) Immune Globulin market is projected to reach US$ 62 million in 2034, increasing from US$ 35 million in 2022, with the CAGR of 7.1% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Rho(D) Immune Globulin market research.
Key manufacturers engaged in the Human Rho(D) Immune Globulin industry include СЅL Веhrіng, Grіfоlѕ, Bayer, Kedrion Biopharma and Saol Therapeutics, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Human Rho(D) Immune Globulin were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Human Rho(D) Immune Globulin market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Rho(D) Immune Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
СЅL Веhrіng
Grіfоlѕ
Bayer
Kedrion Biopharma
Saol Therapeutics
Segment by Type
Vial
Prefilled Syringe
Segment by Application
Government Institution
Private Sector
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Human Rho(D) Immune Globulin report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices